Today's Low
₹ 1,562.15
Today's High
₹ 1,606.60
52 Weeks Low
₹ 651.10
52 Weeks High
₹ 1,045.00
Lower
₹ 1,226.85
Upper
₹ 1,840.25
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 864.9 | 783.4 | 747.8 | 350.0 | 329.3 | 255.2 | 204.9 | 170.6 | 159.5 | 120.4 | 94.4 | 80.9 | 64.9 | 60.2 | 41.2 | 34.3 |
Total Non-Current Assets | 770.2 | 593.4 | 519.6 | 449.5 | 352.3 | 309.6 | 252.0 | 216.8 | 204.5 | 165.7 | 120.1 | 100.9 | 88.5 | 69.7 | 65.3 | 62.6 |
Total Assets | 1,635.1 | 1,376.8 | 1,267.4 | 799.5 | 681.6 | 564.8 | 457.0 | 387.4 | 364.0 | 286.1 | 214.5 | 181.8 | 153.3 | 129.8 | 106.5 | 97.0 |
Total Current Liabilities | 351.2 | 226.7 | 215.1 | 225.5 | 181.2 | 122.6 | 113.9 | 109.3 | 112.6 | 88.9 | 67.6 | 60.8 | 57.1 | 32.0 | 18.3 | 16.4 |
Total Non-Current Liabilities | 42.3 | 62.7 | 86.8 | 139.2 | 119.0 | 104.0 | 71.6 | 49.5 | 55.2 | 50.7 | 34.4 | 27.3 | 18.1 | 37.2 | 40.0 | 38.3 |
Shareholder's Funds | 1,241.6 | 1,087.5 | 965.6 | 434.8 | 381.4 | 338.3 | 271.5 | 228.6 | 196.2 | 146.5 | 112.5 | 93.5 | 78.1 | 60.5 | 48.0 | 42.1 |
Total Liabilities | 1,635.1 | 1,376.8 | 1,267.4 | 799.5 | 681.6 | 564.8 | 457.0 | 387.4 | 364.0 | 286.1 | 214.5 | 181.8 | 153.3 | 129.8 | 106.5 | 97.0 |
The Industry Current Ratio stands at 2.86, vs the Current Ratio of 1.55, which results in a Negative aspect.
The Industry Quick Ratio stands at 2.22, vs the Quick Ratio of 1.06, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.21, vs the Debt to Equity Ratio of 0.47, which results in a Negative aspect.
The Industry Price to BV stands at 10.54, vs the Price to BV of 10.70, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 1,115.2 | 923.1 | 786.5 | 687.2 | 610.8 | 520.4 | 455.0 | 412.3 | 390.4 | 322.3 | 259.8 | 217.0 | 173.0 | 137.2 | 112.2 | 88.4 |
Total Expenditure | 847.8 | 708.1 | 570.0 | 521.1 | 479.6 | 398.5 | 361.5 | 324.5 | 304.3 | 246.5 | 206.9 | 169.3 | 135.3 | 108.1 | 98.1 | 76.4 |
Operating Profit(Excl OI) | 303.6 | 252.9 | 234.9 | 184.6 | 149.7 | 136.3 | 107.0 | 96.0 | 94.2 | 76.8 | 53.2 | 48.3 | 38.0 | 29.6 | 18.5 | 18.1 |
Add: Other Income | 36.2 | 37.9 | 18.4 | 18.5 | 18.5 | 14.4 | 13.5 | 8.3 | 8.1 | 1.1 | 0.3 | 0.6 | 0.4 | 0.5 | 4.4 | 6.1 |
Operating Profit | 303.6 | 252.9 | 234.9 | 184.6 | 149.7 | 136.3 | 107.0 | 96.0 | 94.2 | 76.8 | 53.2 | 48.3 | 38.0 | 29.6 | 18.5 | 18.1 |
Less: Interest | 10.9 | 6.2 | 10.6 | 20.5 | 13.8 | 11.6 | 8.7 | 10.0 | 10.3 | 9.5 | 7.1 | 7.8 | 5.2 | 4.8 | 5.5 | 4.3 |
PBDT | 292.7 | 246.8 | 224.3 | 164.1 | 136.0 | 124.8 | 98.3 | 86.1 | 83.9 | 67.3 | 46.0 | 40.6 | 32.8 | 24.8 | 13.1 | 13.8 |
Less: Depreciation Amortization | 57.2 | 54.0 | 47.5 | 40.5 | 37.3 | 29.2 | 23.7 | 21.0 | 18.8 | 14.1 | 13.0 | 11.7 | 9.4 | 7.8 | 6.7 | 5.7 |
PBT & Exceptional Items | 235.6 | 192.8 | 176.7 | 123.6 | 98.7 | 95.5 | 74.6 | 65.0 | 65.2 | 53.2 | 33.1 | 28.8 | 23.4 | 17.0 | 6.3 | 8.0 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 19.6 | 9.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 237.5 | 195.2 | 180.1 | 125.7 | 100.1 | 96.8 | 75.2 | 65.0 | 84.8 | 63.2 | 33.1 | 28.8 | 23.4 | 17.6 | 6.6 | 8.0 |
Less: Taxation | 58.2 | 48.7 | 44.2 | 29.9 | 34.7 | 26.2 | 20.1 | 17.6 | 23.1 | 19.1 | 9.8 | 9.6 | 2.2 | 1.8 | 0.7 | 0.4 |
Profit After Tax | 179.3 | 146.5 | 135.9 | 95.9 | 65.4 | 70.6 | 55.1 | 47.5 | 61.7 | 44.0 | 23.3 | 19.2 | 21.2 | 15.7 | 5.9 | 7.6 |
Earnings Per Share | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Growth stands at 31.38, vs the PAT Growth of 46.60, which results in a Positive aspect.
The Industry PAT Margin stands at 15.60, vs the PAT Margin of 13.89, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.19, vs the Dividend Yield of 0.19, which results in a Positive aspect.
The Industry PE Ratio stands at 65.35, vs the PE Ratio of 60.35, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 237.5 | 195.2 | 180.1 | 125.7 | 98.7 | 95.5 | 74.6 | 65.0 | 65.2 | 53.2 | 33.1 | 28.8 | 23.4 | 17.6 | 6.6 |
Tax Paid | -57.9 | -47.5 | -44.6 | -35.9 | -27.7 | -23.1 | -18.2 | -13.9 | -23.3 | -17.7 | -7.0 | -5.8 | -4.6 | -2.7 | -0.8 |
Adjustment | 61.2 | 39.1 | 44.5 | 50.6 | 44.2 | 39.9 | 23.3 | 26.0 | 43.0 | 32.9 | 18.6 | 18.0 | 12.6 | 11.8 | 11.3 |
Changes In Working Capital | 237.5 | 195.2 | 180.1 | 125.7 | 98.7 | 95.5 | 74.6 | 65.0 | 65.2 | 53.2 | 33.1 | 28.8 | 23.4 | 17.6 | 6.6 |
Cash Flow after changes in Working Capital | 248.7 | 170.9 | 163.4 | 164.2 | 134.2 | 98.1 | 74.3 | 77.1 | 87.2 | 83.8 | 45.8 | 38.8 | 27.1 | 24.0 | 14.4 |
Cash Flow from Operating Activities | 190.8 | 123.5 | 118.7 | 128.3 | 106.5 | 75.0 | 56.1 | 63.2 | 63.3 | 66.1 | 38.8 | 33.0 | 22.5 | 21.3 | 13.6 |
Cash Flow from Investing Activities | -179.0 | -85.3 | -435.6 | -107.3 | -100.7 | -88.0 | -55.7 | -31.4 | -59.3 | -58.5 | -30.6 | -26.5 | -23.7 | -12.0 | -7.3 |
Cash Flow from Financing Activities | -12.5 | -35.3 | 316.9 | -20.5 | -5.1 | 15.7 | -0.3 | -30.8 | -5.9 | 5.4 | -8.0 | -6.5 | 0.6 | -9.0 | -6.3 |
Net Cash Inflow / Outflow | -0.7 | 2.8 | 0.1 | 0.5 | 0.6 | 2.6 | 0.1 | 1.1 | -1.9 | 13.1 | 0.2 | 0.1 | -0.6 | 0.3 | 0.0 |
Opening Cash & Cash Equivalents | 7.8 | 5.0 | 4.9 | 4.3 | 3.7 | 1.1 | 1.0 | 11.9 | 13.8 | 0.7 | 0.6 | 0.5 | 1.1 | 0.8 | 0.7 |
Closing Cash & Cash Equivalent | 7.1 | 7.8 | 5.0 | 4.9 | 4.3 | 3.7 | 1.1 | 12.9 | 11.9 | 13.8 | 0.8 | 0.6 | 0.5 | 1.1 | 0.8 |
The Industry PFCF Ratio stands at -61.68, vs the PFCF Ratio of 113.54, which results in a Positive aspect.
The Industry PCF RATIO stands at 54.65, vs the PCF RATIO of 16.20, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 3,396.0 | 3,372.9 | 3,208.3 | 3,068.5 | 2,848.3 | 2,747.0 | 2,488.5 | 2,575.2 | 2,302.8 | 2,233.7 | 2,119.4 | 2,129.6 | 2,035.1 | 1,996.3 | 1,703.8 | 1,713.3 |
Total Income | 3,561.7 | 3,513.9 | 3,339.5 | 3,153.5 | 2,992.6 | 2,833.9 | 2,534.2 | 2,657.1 | 2,374.1 | 2,356.3 | 2,222.1 | 2,196.3 | 2,085.5 | 2,028.6 | 1,738.4 | 1,765.6 |
Total Expenditure | 2,493.8 | 2,530.7 | 2,336.4 | 2,236.4 | 2,138.1 | 2,100.1 | 2,023.8 | 2,017.7 | 1,790.9 | 1,725.0 | 1,566.1 | 1,587.7 | 1,457.0 | 1,431.1 | 1,245.3 | 1,311.8 |
PBIDT (Excl OI) | 902.2 | 842.3 | 871.9 | 832.1 | 710.2 | 646.8 | 464.7 | 557.5 | 511.9 | 508.7 | 553.4 | 541.9 | 578.1 | 565.2 | 458.5 | 401.5 |
Other Income | 165.7 | 140.9 | 131.2 | 84.9 | 144.3 | 86.9 | 45.7 | 82.0 | 71.4 | 122.6 | 102.8 | 66.7 | 50.4 | 32.4 | 34.7 | 52.3 |
Operating Profit | 1,067.9 | 983.2 | 1,003.1 | 917.1 | 854.5 | 733.7 | 510.4 | 639.5 | 583.3 | 631.3 | 656.1 | 608.6 | 628.5 | 597.5 | 493.2 | 453.8 |
Interest | 34.7 | 22.2 | 24.9 | 23.5 | 48.3 | 4.5 | 12.1 | 14.5 | -5.8 | 2.0 | 31.9 | -18.3 | 47.8 | 27.7 | 27.9 | 80.8 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 1,033.2 | 961.0 | 978.2 | 893.6 | 806.3 | 729.2 | 498.3 | 625.0 | 589.1 | 629.3 | 624.2 | 626.9 | 580.7 | 569.8 | 465.3 | 373.0 |
Depreciation | 162.1 | 159.9 | 155.3 | 147.9 | 141.9 | 142.5 | 139.4 | 139.9 | 136.0 | 135.0 | 128.7 | 125.4 | 125.6 | 114.4 | 109.8 | 94.8 |
Profit Before Tax | 871.1 | 801.1 | 822.9 | 745.7 | 664.3 | 586.7 | 358.9 | 485.1 | 453.1 | 494.3 | 495.4 | 501.5 | 455.1 | 455.4 | 355.5 | 278.2 |
Tax | 228.1 | 187.6 | 203.5 | 163.5 | 167.8 | 157.5 | 93.3 | 126.3 | 113.3 | 121.9 | 126.0 | 129.7 | 107.1 | 109.6 | 95.3 | 62.4 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 643.0 | 613.5 | 619.5 | 582.2 | 496.5 | 429.2 | 265.7 | 358.8 | 339.8 | 372.5 | 369.4 | 371.7 | 348.0 | 345.8 | 260.2 | 215.8 |
Net Profit | 643.0 | 613.5 | 619.5 | 582.2 | 496.5 | 429.2 | 265.7 | 358.8 | 339.8 | 372.5 | 369.4 | 371.7 | 348.0 | 345.8 | 260.2 | 215.8 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 479.7 | 479.7 | 479.7 | 479.7 | 479.6 | 479.6 | 479.5 | 479.5 | 479.5 | 479.4 | 479.4 | 479.4 | 441.2 | 441.2 | 441.2 | 441.2 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 6.8 | 6.5 | 6.5 | 6.1 | 5.2 | 4.5 | 2.8 | 3.8 | 3.6 | 4.0 | 3.9 | 4.3 | 54.0 | 4.0 | 3.0 | 2.6 |
Operating Profit Margin | 31.4 | 29.1 | 31.3 | 29.9 | 30.0 | 26.7 | 20.5 | 24.8 | 25.3 | 28.3 | 31.0 | 28.6 | 30.9 | 29.9 | 28.9 | 26.5 |
Net Profit Margin | 18.9 | 18.2 | 19.3 | 19.0 | 17.4 | 15.6 | 10.7 | 13.9 | 14.8 | 16.7 | 17.4 | 17.5 | 17.1 | 17.3 | 15.3 | 12.6 |
The Industry Net Sales Growth stands at 16.62, vs the Net Sales Growth of 12.51, which results in a Negative aspect.
The Industry Mcap Growth stands at 74.40, vs the Mcap Growth of 8.56, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,701.30 | 1,779.80 | 1,601.25 |
R3 | 1,673.13 | 1,666.80 | 1,582.28 |
R2 | 1,644.97 | 1,641.80 | 1,575.95 |
R1 | 1,604.13 | 1,597.80 | 1,569.63 |
Pivot | 1,575.97 | 1,572.80 | 1,575.97 |
S1 | 1,535.13 | 1,528.80 | 1,556.98 |
S2 | 1,506.97 | 1,503.80 | 1,550.65 |
S3 | 1,466.13 | 1,459.80 | 1,544.33 |
S4 | 1,425.30 | 1,365.80 | 1,525.35 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
100.00
Bearish
RSI
54.72
Neutral
ROC
1.40
Bullish
UltimateOscillator
53.17
Neutral
Williams Indicator
-26.64
Neutral
CCI Indicator
100.38
Neutral
MACD
-1,768.51
Bearish
Stochastic Indicator
67.01
Neutral
ATR
51.49
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
21-09-2023 | 3.00 | 60 | Final |
16-09-2022 | 2.50 | 50 | Final |
16-09-2021 | 2.50 | 50 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
08-03-2024 | Inter alia, to consider the following:- a) Business Plan for Financial Year 2024-25. b) consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s) and / or combination(s) thereof as may be considered appropriate, by way of raising of debts, issuance of any instruments or securities, through private placement, preferential issue, rights issue, qualified institutions placement or such other methods or combinations thereof as may be decided by the Board, subject to such approvals as may be required, and to transact other businesses with the permission of the Chairperson. |
31-01-2024 | Quarterly Results |
04-11-2023 | Quarterly Results |
07-08-2023 | Quarterly Results |
09-05-2023 | Final Dividend & Audited Results |
28-01-2023 | Quarterly Results |
04-11-2022 | Quarterly Results |
04-08-2022 | Quarterly Results |
24-05-2022 | Final Dividend & Audited Results |
31-01-2022 | Quarterly Results |
01-11-2021 | Quarterly Results |
29-07-2021 | Quarterly Results |
24-05-2021 | Dividend & Audited Results Iinter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2021. b) To consider recommendation of Final Dividend, if any, on the Equity Shares for the financial year ended on 31st March, 2021. c) To transact any other matter which the Board may deem fit. |